Publication | Closed Access

Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia**A complete list of participants in the Research Group and Publication Committee appears in the Appendix.

Drug SafetyCardiovascular DiseaseMedicinePublication CommitteePharmacotherapyOnce-daily Niacin/lovastatin FormulationLong-term SafetyPharmacologyDyslipidemia